Milae Bioresources Co., Ltd. (KOSDAQ:218150)
1,800.00
+178.00 (10.97%)
At close: Jun 29, 2026
Milae Bioresources Revenue
Milae Bioresources had revenue of 17.04B KRW in the quarter ending March 31, 2026, with 15.87% growth. This brings the company's revenue in the last twelve months to 69.89B, up 11.45% year-over-year. In the year 2025, Milae Bioresources had annual revenue of 67.55B with 8.17% growth.
Revenue (ttm)
69.89B
Revenue Growth
+11.45%
P/S Ratio
0.50
Revenue / Employee
1.49B
Employees
47
Market Cap
35.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.55B | 5.10B | 8.17% |
| Dec 31, 2024 | 62.45B | 2.44B | 4.06% |
| Dec 31, 2023 | 60.02B | -15.62B | -20.65% |
| Dec 31, 2022 | 75.64B | 8.97B | 13.45% |
| Dec 31, 2021 | 66.67B | 19.17B | 40.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sewon Co.,Ltd | 242.11B |
| Cubic Korea | 221.26B |
| EE-HWA Construction | 107.87B |
| nTels | 68.14B |
| C&R Research | 62.70B |
| HuM&C | 54.29B |
| FASOO AI | 47.25B |
| RN2 Technologies | 18.81B |